Total Liabilities Summary of MedMira Inc.

MedMira Inc.'s latest annual total liabilities in 2023 was 18.68 Million CAD , up 15.43% from previous year.
MedMira Inc.'s latest quarterly total liabilities in 2024 Q3 was 23.22 Million CAD , up 13.04% from previous quarter.
MedMira Inc. reported annual total liabilities of 16.18 Million CAD in 2022, down -17.48% from previous year.
MedMira Inc. reported annual total liabilities of 19.61 Million CAD in 2021, up 3.46% from previous year.
MedMira Inc. reported quarterly total liabilities of 20.39 Million CAD for 2024 Q1, up 9.18% from previous quarter.
MedMira Inc. reported quarterly total liabilities of 23.22 Million CAD for 2024 Q3, up 13.04% from previous quarter.

Annual Total Liabilities Chart of MedMira Inc. (2023 - 2000)

Historical Annual Total Liabilities of MedMira Inc. (2023 - 2000)

Year	Total Liabilities	Total Liabilities Growth
2023	18.68 Million CAD	15.43%
2022	16.18 Million CAD	-17.48%
2021	19.61 Million CAD	3.46%
2020	18.95 Million CAD	37.68%
2019	13.76 Million CAD	17.7%
2018	11.69 Million CAD	21.13%
2017	9.65 Million CAD	13.2%
2016	8.53 Million CAD	-10.08%
2015	9.48 Million CAD	11.21%
2014	8.53 Million CAD	-16.98%
2013	10.27 Million CAD	-12.0%
2012	11.67 Million CAD	-43.32%
2011	20.6 Million CAD	19.58%
2010	17.23 Million CAD	4.31%
2009	16.52 Million CAD	11.82%
2008	14.77 Million CAD	-5.55%
2007	15.64 Million CAD	29.77%
2006	12.05 Million CAD	7.31%
2005	11.23 Million CAD	48.44%
2004	7.56 Million CAD	66.42%
2003	4.54 Million CAD	-57.93%
2002	10.8 Million CAD	19.65%
2001	9.03 Million CAD	31.06%
2000	6.89 Million CAD	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	20.54 Million CAD	0.73%
2024 Q1	20.39 Million CAD	9.18%
2024 Q3	23.22 Million CAD	13.04%
2023 Q2	17.2 Million CAD	2.61%
2023 FY	18.68 Million CAD	15.43%
2023 Q1	16.76 Million CAD	3.58%
2023 Q4	18.68 Million CAD	4.39%
2023 Q3	17.89 Million CAD	4.04%
2022 Q2	16.03 Million CAD	-23.95%
2022 Q4	16.18 Million CAD	1.22%
2022 Q1	21.08 Million CAD	7.49%
2022 FY	16.18 Million CAD	-17.48%
2022 Q3	15.99 Million CAD	-0.28%
2021 Q1	19.4 Million CAD	2.37%
2021 Q2	19.24 Million CAD	-0.83%
2021 FY	19.61 Million CAD	3.46%
2021 Q3	19.26 Million CAD	0.09%
2021 Q4	19.61 Million CAD	1.81%
2020 Q1	16.65 Million CAD	20.92%
2020 Q2	17.43 Million CAD	4.7%
2020 Q3	18.39 Million CAD	5.5%
2020 Q4	18.95 Million CAD	3.09%
2020 FY	18.95 Million CAD	37.68%
2019 FY	13.76 Million CAD	17.7%
2019 Q4	13.76 Million CAD	3.29%
2019 Q3	13.33 Million CAD	3.61%
2019 Q2	12.86 Million CAD	5.44%
2019 Q1	12.2 Million CAD	4.31%
2018 Q4	11.69 Million CAD	4.71%
2018 FY	11.69 Million CAD	21.13%
2018 Q1	10.15 Million CAD	5.18%
2018 Q2	10.6 Million CAD	4.36%
2018 Q3	11.17 Million CAD	5.39%
2017 Q4	9.65 Million CAD	5.7%
2017 Q2	8.5 Million CAD	-0.4%
2017 Q1	8.53 Million CAD	0.07%
2017 Q3	9.13 Million CAD	7.46%
2017 FY	9.65 Million CAD	13.2%
2016 Q4	8.53 Million CAD	7.36%
2016 FY	8.53 Million CAD	-10.08%
2016 Q3	7.94 Million CAD	-6.23%
2016 Q2	8.47 Million CAD	1.49%
2016 Q1	8.35 Million CAD	-11.98%
2015 FY	9.48 Million CAD	11.21%
2015 Q3	8.68 Million CAD	-2.53%
2015 Q4	9.48 Million CAD	9.21%
2015 Q1	8.32 Million CAD	-2.41%
2015 Q2	8.91 Million CAD	7.06%
2014 Q4	8.53 Million CAD	2.82%
2014 Q1	9.6 Million CAD	-6.52%
2014 FY	8.53 Million CAD	-16.98%
2014 Q2	8.88 Million CAD	-7.47%
2014 Q3	8.29 Million CAD	-6.66%
2013 Q3	9.21 Million CAD	5.07%
2013 Q1	10.76 Million CAD	-7.82%
2013 FY	10.27 Million CAD	-12.0%
2013 Q4	10.27 Million CAD	11.59%
2013 Q2	8.76 Million CAD	-18.58%
2012 Q1	21.47 Million CAD	4.22%
2012 Q3	23.5 Million CAD	7.35%
2012 FY	11.67 Million CAD	-43.32%
2012 Q4	11.67 Million CAD	-50.31%
2012 Q2	21.89 Million CAD	1.94%
2011 Q2	18.66 Million CAD	1.43%
2011 Q1	18.39 Million CAD	6.77%
2011 Q3	19.49 Million CAD	4.44%
2011 Q4	20.6 Million CAD	5.72%
2011 FY	20.6 Million CAD	19.58%
2010 FY	17.23 Million CAD	4.31%
2010 Q1	15.84 Million CAD	-4.07%
2010 Q2	15.52 Million CAD	-2.04%
2010 Q3	15.97 Million CAD	2.89%
2010 Q4	17.23 Million CAD	7.88%
2009 Q1	15.89 Million CAD	7.62%
2009 Q2	16.17 Million CAD	1.72%
2009 Q3	16.49 Million CAD	2.02%
2009 Q4	16.52 Million CAD	0.13%
2009 FY	16.52 Million CAD	11.82%
2008 Q1	15.96 Million CAD	2.04%
2008 FY	14.77 Million CAD	-5.55%
2008 Q4	14.77 Million CAD	3.84%
2008 Q3	14.22 Million CAD	-7.81%
2008 Q2	15.43 Million CAD	-3.31%
2007 FY	15.64 Million CAD	29.77%
2007 Q1	13.13 Million CAD	8.94%
2007 Q3	14.71 Million CAD	1.97%
2007 Q4	15.64 Million CAD	6.29%
2007 Q2	14.43 Million CAD	9.91%
2006 FY	12.05 Million CAD	7.31%
2006 Q4	12.05 Million CAD	16.51%
2006 Q3	10.34 Million CAD	-28.79%
2006 Q1	13.22 Million CAD	17.77%
2006 Q2	14.52 Million CAD	9.82%
2005 Q4	11.23 Million CAD	18.55%
2005 FY	11.23 Million CAD	48.44%
2005 Q1	7.99 Million CAD	5.71%
2005 Q2	9.2 Million CAD	15.02%
2005 Q3	9.47 Million CAD	2.98%
2004 Q1	4.71 Million CAD	3.61%
2004 FY	7.56 Million CAD	66.42%
2004 Q3	6.53 Million CAD	15.39%
2004 Q4	7.56 Million CAD	15.83%
2004 Q2	5.66 Million CAD	20.17%
2003 Q3	11.48 Million CAD	10.31%
2003 Q1	10.69 Million CAD	-1.08%
2003 FY	4.54 Million CAD	-57.93%
2003 Q2	10.41 Million CAD	-2.63%
2003 Q4	4.54 Million CAD	-60.41%
2002 Q3	11.38 Million CAD	4.79%
2002 FY	10.8 Million CAD	19.65%
2002 Q2	10.86 Million CAD	8.75%
2002 Q4	10.8 Million CAD	-5.07%
2002 Q1	9.99 Million CAD	0.0%
2001 FY	9.03 Million CAD	31.06%
2000 FY	6.89 Million CAD	0.0%

Peer Total Liabilities Comparison of MedMira Inc.

Name	Total Liabilities	Total Liabilities Difference
Arch Biopartners Inc.	6.68 Million CAD	-179.651%
Covalon Technologies Ltd.	6.1 Million CAD	-205.896%
Hemostemix Inc.	7.68 Million CAD	-143.116%
Universal Ibogaine Inc.	2.37 Million CAD	-686.783%
Kane Biotech Inc.	14.09 Million CAD	-32.598%
Marvel Biosciences Corp.	2.39 Million CAD	-680.925%
NervGen Pharma Corp.	15.24 Million CAD	-22.554%
XORTX Therapeutics Inc.	1.08 Million CAD	-1615.525%

Global Stocks Search

MedMira Inc. (MIR.V)

Total Liabilities Summary of MedMira Inc.

Annual Total Liabilities Chart of MedMira Inc. (2023 - 2000)

Historical Annual Total Liabilities of MedMira Inc. (2023 - 2000)

Peer Total Liabilities Comparison of MedMira Inc.